Rapid Micro Biosystems, Inc. (RPID) stock
RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3050% below fair value
$0.74−0.00 (-0.43%)
Close on Nov 17, 2026Market cap $36.96MP/E –Yield –
Rapid Micro Biosystems revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Rapid Micro Biosystems's revenue for the twelve months ending Jun 30, 2026 was $35.18M, up 16.1% year over year. For fiscal 2025 it was $33.59M, up 19.7% from the year before. The highest annual figure on record is $33.59M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.59M | +19.7% |
| FY2024 | Dec 31, 2024 | $28.05M | +24.6% |
| FY2023 | Dec 31, 2023 | $22.52M | +31.4% |
| FY2022 | Dec 31, 2022 | $17.13M | -26.3% |
| FY2021 | Dec 31, 2021 | $23.23M | +44.5% |
| FY2020 | Dec 31, 2020 | $16.08M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.05M | +10.9% |
| Q1 FY2026 | Mar 31, 2026 | $8.00M | +11.1% |
| Q4 FY2025 | Dec 31, 2025 | $11.28M | +37.3% |
| Q3 FY2025 | Sep 30, 2025 | $7.84M | +3.1% |
| Q2 FY2025 | Jun 30, 2025 | $7.26M | +9.7% |
| Q1 FY2025 | Mar 31, 2025 | $7.21M | +28.4% |
| Q4 FY2024 | Dec 31, 2024 | $8.22M | +29.7% |
| Q3 FY2024 | Sep 30, 2024 | $7.60M | +23.7% |
| Q2 FY2024 | Jun 30, 2024 | $6.62M | +32.3% |
| Q1 FY2024 | Mar 31, 2024 | $5.61M | +11.4% |
| Q4 FY2023 | Dec 31, 2023 | $6.34M | +44.9% |
| Q3 FY2023 | Sep 30, 2023 | $6.15M | +29.7% |
| Q2 FY2023 | Jun 30, 2023 | $5.00M | +29.6% |
| Q1 FY2023 | Mar 31, 2023 | $5.04M | +21.0% |
| Q4 FY2022 | Dec 31, 2022 | $4.37M | -16.0% |
| Q3 FY2022 | Sep 30, 2022 | $4.74M | -31.3% |
| Q2 FY2022 | Jun 30, 2022 | $3.86M | -37.0% |
| Q1 FY2022 | Mar 31, 2022 | $4.16M | -16.7% |
| Q4 FY2021 | Dec 31, 2021 | $5.21M | -0.6% |
| Q3 FY2021 | Sep 30, 2021 | $6.90M | +31.5% |
| Q2 FY2021 | Jun 30, 2021 | $6.13M | +136.4% |
| Q1 FY2021 | Mar 31, 2021 | $5.00M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.24M | – |
| Q3 FY2020 | Sep 30, 2020 | $5.25M | – |
| Q2 FY2020 | Jun 30, 2020 | $2.59M | – |
See a number that looks wrong?